CD19 CAR-T cells trials for Lupus

All CD19 CAR-T cells trials · All Lupus trials

Phase breakdown

Recruiting trials studying CD19 CAR-T cells for Lupus

• Anti-CD19 Chimeric Antigen Receptor T Cells for Refractory Systemic Lupus Erythematosus
  NCT06585514 · Phase: Phase 1, Phase 2 · Ages: 3 Years to 65 Years · Sex: All (male and female) · 1 location
• Autologous CD19 Car T-Cell Therapy For Severe Refractory Systemic Lupus Erythematosus (SLE)
  NCT06710717 · Phase: Phase 1 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• Study of Ultra-Fast CD19 CAR-T Therapy for Refractory SLE
  NCT07331467 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Study of Ultra-Fast CD19 CAR-T Therapy for Refractory SLE
  NCT07233642 · Phase: Phase 1 · Ages: 5 Years and older · Sex: All (male and female) · 1 location

Common questions

How many trials study CD19 CAR-T cells for Lupus?

4 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.